Leemore Dafny discusses antitrust and healthcare under the Biden-Harris administration in ABA webinar

As the industry transitions to the new administration, it is an opportune time to reflect on events and developments pertaining to healthcare and antitrust over the past four years. Partner Leemore Dafny will participate in the webinar “Biden/Harris Administration Retrospective in Healthcare & Pharmaceuticals.” She and co-panelists will discuss the achievements and challenges of the Biden–Harris administration relating to antitrust and healthcare and pharmaceuticals. Dr. Dafny’s co-panelists include Peter Herrick of O’Melveny & Meyers and Mark Seidman of Weil Gotshal & Manges.